Amgen (AMGN) Assets Average (2009 - 2026)

Amgen (AMGN) has reported Assets Average for 17 consecutive years, with $91.5 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Assets Average rose 1.04% year-over-year to $91.5 billion; the TTM figure through Mar 2026 stood at $91.5 billion (up 1.04% YoY), while the FY2025 annual figure was $91.2 billion, down 3.48% from the prior year.
• Assets Average came in at $91.5 billion for Q1 2026 at Amgen, up from $90.4 billion in the prior quarter.
• The five-year high for Assets Average was $95.1 billion in Q1 2024, with the low at $59.2 billion in Q2 2022.
• Average Assets Average over 5 years is $83.3 billion, with a median of $90.4 billion recorded in 2025.
• Across the five-year window, Assets Average surged 51.06% in 2023 and dropped 4.7% in 2025, its largest moves.
• Year by year, Assets Average stood at $64.4 billion in 2022, then jumped by 45.7% to $93.8 billion in 2023, then slipped by 2.65% to $91.4 billion in 2024, then declined by 1.09% to $90.4 billion in 2025, then advanced by 1.31% to $91.5 billion in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $91.5 billion, $90.4 billion, and $89.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.